PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Ryuichi Noguchi Selected Research
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
06/2007
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
02/2007
Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
11/2006
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
01/2006
Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
02/2005
Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
12/2003
Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.
Articles by Research Topic
Disease
7
Hepatocellular Carcinoma (Hepatoma)
01/2008 - 04/2002
6
Liver Cirrhosis (Hepatic Cirrhosis)
11/2007 - 02/2005
4
Neoplasms (Cancer)
01/2006 - 06/2002
2
Chronic Hepatitis C
11/2006 - 02/2005
1
Acute Liver Failure (Fulminant Hepatic Failure)
07/2006
1
Colorectal Neoplasms (Colorectal Cancer)
07/2005
Drug/Important Bio-Agent (IBA)
6
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
06/2007 - 12/2003
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2006 - 04/2002
3
Interferons
IBA
01/2008 - 02/2005
3
Perindopril
FDA Link
02/2005 - 12/2003
2
Vitamin K 2 (Vitamin K2)
IBA
06/2007 - 01/2006
2
Interferon-beta
IBA
02/2005 - 12/2003
1
Adiponectin
IBA
11/2007
1
H-cadherin (T-cadherin)
IBA
11/2007
1
Fluorouracil (Carac)
FDA Link
Generic
02/2007
1
Angiotensin II
IBA
10/2006
1
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
07/2006
1
Copper
IBA
07/2005
1
Triethylenetetramine (Trien)
IBA
07/2005
1
Methotrexate (Mexate)
FDA Link
Generic
07/2005
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
05/2005
1
imatinib (Gleevec)
FDA Link
05/2005
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
11/2004
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
07/2004
1
Tissue Inhibitor of Metalloproteinase-1
IBA
06/2003
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
04/2002